Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+ )T lymphocyte cytokine production

BACKGROUND: The new JAK3 inhibitor, CP690,550, has shown efficacy in the treatment of rheumatoid arthritis. The present study was undertaken to assess the effects of CP690,550 on cytokine production and cellular signaling in human CD4(+ )T cells. RESULTS: CD4(+ )T cells produced IL-2, IL-4, IL-17, I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Migita, Kiyoshi, Miyashita, Taiichiro, Izumi, Yasumori, Koga, Tomohiro, Komori, Atsumasa, Maeda, Yumi, Jiuchi, Yuka, Aiba, Yoshihiro, Yamasaki, Satoshi, Kawakami, Atsushi, Nakamura, Minoru, Ishibashi, Hiromi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3179939/
https://ncbi.nlm.nih.gov/pubmed/21884580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2172-12-51
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados